Spotlight Series on Hepatitis C


Hepatitis C versus the Immune System: The Biology of Hepatitis C Transmission

September 5, 2018

 < Prev  |  1  |  2  |  3 


  1. Foster, AL, Gaisa MM, Hijdra RM, et al. Shedding of hepatitis C virus in to the rectum of HIV-infected men who have sex with men. Clinical Infectious Diseases. 2017;64(3):284-288.
  2. Silverman AL, Puccio JE, Kulesza GW, et al. HCV RNA is present in the menstrual blood of women with chronic hepatitis C infection. American Journal of Gastroenterology. 1994 Aug;89(8):1201-1202.
  3. Terrault NA, Dodge JL, Murphy EL, et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV Partners Study. Hepatology. 2013 Mar;57(3):881-889.
  4. Wang CC, Cook L, Tapia KA, Holte S, et al. Cervicovaginal shedding of hepatitis C viral RNA is associated with the presence of menstrual or other blood in cervicovaginal fluids. Journal of Clinical Virology. 2011 Jan;50(1):4-7.
  5. Lohiya G-S, Tan-Figueroa L, Lohiya S, Lohiya S. Human bites: bloodborne pathogen risk and postexposure follow-up algorithm. Journal of the National Medical Association. 2013;105(1):92-95.
  6. European Paediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. BJOG. 2001 Apr;108(4):371-377.
  7. Canadian Paediatric Society. Vertical transmission of the hepatitis C virus: Current knowledge and issues. Available from:
  8. Ferreiro MC, Dios PD, Scully C. Transmission of hepatitis C virus by saliva? Oral Diseases. 2005 Jul 1;11(4):230-235.
  9. Fethers K, Marks C, Mindel A, Estcourt C. Sexually transmitted infections and risk behaviours in women who have sex with women. Sexually Transmitted Infections. 2000 Oct;76(5):345-349.
  10. Miller ER, McNally S, Wallace J, Schlichthorst M. The ongoing impacts of hepatitis c - a systematic narrative review of the literature. BMC Public Health. 2012 Aug 18;12:672.
  11. Kaplan-Lewis E, Fierer DS. Acute HCV in HIV-infected MSM: modes of acquisition, liver fibrosis, and treatment. Current HIV/AIDS Reports. 2015 Sep;12(3):317-325.
  12. Trubnikov M, Yan P, Archibald C. Estimated prevalence of hepatitis C virus infection in Canada, 2011. Canada Communicable Disease Report. 18 December 2014;40(19). Available from:
  13. Petruzziello A, Marigliano S, Loquercio G, et al. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World Journal of Gastroenterology. 2016 Sep 14;22(34):7824-7840.
  14. Jin F, Matthews GV, Grulich AE. Sexual transmission of hepatitis C virus among gay and bisexual men: a systematic review. Sexual Health. 2017;14:28-41.
  15. Hagan H, Jordan AE, Neurer J, Cleland CM. Incidence of sexually-transmitted hepatitis C virus infection in HIV-positive men who have sex with men: A systematic review and meta-analysis. AIDS. 2015 Nov;29(17):2335-2345.
  16. Chan DP, Sun H-Y, Wong HT, et al. Sexually acquired hepatitis C virus infection: a review. International Journal of Infectious Diseases. 2016;49:47-58.
  17. Vanhommerig JW, Lambers FAE, Schinkel J, et al. Risk factors for sexual transmission of hepatitis C virus among human immunodeficiency virus-infected men who have sex with men: A case-control study. Open Forum Infectious Diseases. 2015 Aug 6;2(3). Available from:
  18. Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology. 2010;52(4):1497-1505.
  19. Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clinical Infectious Diseases. 2014 Sep 15;59(6):765-773.
  20. Ding Q, von Schaewen M, Ploss A. The impact of hepatitis C virus entry on viral tropism. Cell Host & Microbe. 2014 Nov 12;16(5):562-568.
  21. Kim CW, Chang K-M. Hepatitis C virus: virology and life cycle. Clinical and Molecular Hepatology. 2013 Mar;19(1):17-25.
  22. Manns MP, Foster GR, Rockstroh JK, et al. The way forward in HCV treatment--finding the right path. Nature Reviews Drug Discovery. 2007 Dec;6(12):991-1000.
  23. Dustin LB, Bartolini B, Capobianchi MR, Pistello M. Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy. Clinical Microbiology and Infection. 2016 Oct 1;22(10):826-832.
  24. Lauer GM. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies. Journal of Infectious Disease. 2013 Mar 15;207(suppl_1):S7-S12.
  25. Koziel MJ. Cellular immune responses against hepatitis C virus. Clinical Infectious Diseases. 2005 Jul 1;41(Supplement 1):S25-3S1.
  26. Burke KP, Cox AL. Hepatitis C virus evasion of adaptive immune responses -- A model for viral persistence. Immunologic Research. 2010 Jul;47(1-3):216-227.
  27. Echeverría N, Moratorio G, Cristina J, Moreno P. Hepatitis C virus genetic variability and evolution. World Journal of Hepatology. 2015 Apr 28;7(6):831-845.
  28. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. Journal of Viral Hepatitis. 2006 Jan;13(1):34-41.
  29. Grebely J, Page K, Sacks-Davis R, et al. The effects of female sex, viral genotype and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014 Jan;59(1):109-120.
  30. Dustin LB. Innate and adaptive immune responses in chronic HCV infection. Current Drug Targets. 2017;18(7):826-843.
  31. Aisyah DN, Shallcross L, Hully AJ, O'Brien A, Hayward A. Assessing hepatitis C spontaneous clearance and understanding associated factors -- A systematic review and meta-analysis. Journal of Viral Hepatitis. 2018 Jun;25(6):690-698. Available from:
  32. Hepatitis C Trust. How hepatitis C damages the liver. [Online]. Available from:
  33. Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World Journal of Gastroenterology. 2014 Aug 28;20(32):11033-11053.
  34. Lee YA, Friedman SL. Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C? Antiviral Research. 2014 Jul;107:23-30. Available from:
  35. Kugelmas M. Extrahepatic benefits achieved with sustained virologic response in patients with hepatitis C virus infection. Gastroenterology & Hepatology. 2017 Sep;13(9):553-555.
  36. Smith-Palmer J, Cerri K, Valentine W. Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits. BMC Infectious Diseases. 2015 Jan 17;15:19. Avaialble from:
  37. Mahale P, Engels EA, Li R, et al. The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection. Gut. 2018 Mar 1;67(3):553-561.

[Note from TheBodyPRO: This article was originally published by CATIE in Aug. 2018. We have cross-posted it with their permission.]

 < Prev  |  1  |  2  |  3 

Related Stories

Hepatitis C: How Is It Transmitted and Who Should Be Tested?
An Overview of Hepatitis C Transmission and Prevention
Overview of HCV Disease Progression

This article was provided by Canadian AIDS Treatment Information Exchange. It is a part of the publication Prevention in Focus: Spotlight on Programming and Research. Visit CATIE's Web site to find out more about their activities, publications and services.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.